Laboratory Medicine ›› 2026, Vol. 41 ›› Issue (2): 118-125.DOI: 10.3969/j.issn.1673-8640.2026.02.004
Previous Articles Next Articles
FU Wanyu, XIAO Shanshan, JIANG Yuying, LI Yanqing(
)
Received:2025-01-07
Revised:2025-08-01
Online:2026-02-28
Published:2026-03-06
CLC Number:
FU Wanyu, XIAO Shanshan, JIANG Yuying, LI Yanqing. Genetic analysis of fetal chromosome 12 copy number variation and follow-up of pregnancy outcomes[J]. Laboratory Medicine, 2026, 41(2): 118-125.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2026.02.004
| 序号 | 孕妇年龄 | 胎儿 染色体 核型 | 产前诊断指征 | SNP-array | OMIM基因/个 | 临床 意义 | 证据项 | 综合征 | 父母验证 | 妊娠结局 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 25岁 | 46,XN,der(1)t(1;12)(p36.3;q24.1) | 透明隔腔偏窄、后颅窝池增宽、心包积液 | [hg19]1p36.33p36.32(849,467-2579,267)x1; | 47 | 致病性 CNV | 1A(0)、2H(0.15)、3C(0.9)、4C(0.3)(PMID:25125236,23892090)、5A(0.15);总分为1.50分 | 1p36缺失综合征 | 遗传至母亲 | 终止妊娠 |
| 12q24.13q24.33(114,095,026-133,777,562)x3 | 122 | 致病性CNV | 1A(0)、2H(0)、3C(0.9)、4C(0.3)(patient:402518,296364;PMID:15216553)、5A(0.15);总分为1.35分 | 12号染色体长臂(12q)部分三体综合征 | ||||||
| 2 | 41岁 | 47,XN,+dic(12)(q12)[3]/46,XN[97] | 高龄孕妇;羊水过多;肠道强回声;肾盂扩张 | [hg19]12p13.33q12(173,786-40,380,906)x3-4 | 244 | 致病性CNV | 1A(0)、2H(0)、3C(0.9)、4C(0.9)(patient:282283,284998,339519,266262,389885,350633,270856;PMID:2758689,15633165,2887316)、5A(0.15);总分为1.95分 | PKS | 新发变异 | 终止妊娠 |
| 3 | 29岁 | 47,XN,+i(12)(p10) | 长骨短小;侧脑室增宽;肾盂扩张;NF增厚 | [hg19]12p13.33p11.1(173,786-34,835,641)x4 | 241 | 致病性CNV | 1A(0)、2H(0)、3C(0.9)、4C(0.9)(patient:282283,284998,339519,266262,389885,350633,270856;PMID:2758689,15633165,2887316)、5A(0.15);总分为1.95分 | PKS | 新发变异 | 终止妊娠 |
| 4 | 32岁 | 培养失败 | FGR | [hg19]12p13.31(5,922,932-8,146,162)x3 | 60 | 可能致病性CNV | 1A(0)、2L(0)、3C(0.9)、5C(-0.15);总分为0.75分 | 遗传自母亲 | 终止妊娠 | |
| 15q15.2(43,272,083-43,451,905)x1 | 1 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.15分 | 遗传自父亲 | ||||||
| 5 | 31岁 | 未见异常 | 肠道强回声;心脏强回声 | [hg19]12p13.33(1,953,989-2,773,408)x3 | 2 | 临床意义未明CNV | 1A(0)、3A(0)、5A(0.15);总分为0.15分 | 新发突变 | 继续妊娠 | |
| 6 | 32岁 | 未见异常 | DS风险率1︰164;侵蚀性葡萄胎孕产史 | [hg19]12p13.31(6,027,291-6,685,880)x3 | 17 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.15分 | 遗传自父亲 | 继续妊娠 | |
| 7 | 28岁 | 未见异常 | 既往因胎儿唇裂伴肺静脉异位引流引产;脐血染色体提示12p11.23缺失513.213 kb、16q24.1重复110.97 kb | [hg19]12p11.23(27,283,452-27,796,495)x1 | 3 | 临床意义未明CNV | 1A(0)、3A(0)、4O(-0.3)[gnomad:DEL_12_126655(2/21674)]、5C(-0.15);总分为-0.45分 | 遗传自母亲 | 继续妊娠 | |
| 8 | 33岁 | 未见异常 | 既往18-三体儿引产史 | [hg19]12p13.33(1,889,823-2,539,307)x3 | 5 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自父亲 | 继续妊娠 | |
| 5p15.33(1,014,640-1,277,743)x3 | 5 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自母亲 | ||||||
| 9 | 30岁 | 未见异常 | 既往21-三体儿引产史 | [hg19]12q13.12(50,462,917-50,790,693)x1 | 6 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自母亲 | 继续妊娠 | |
| 10 | 29岁 | 未见异常 | 夫妻双方均为α-地中海贫血基因携带者,胎儿脉络丛囊肿 | [hg19]12q23.1(97,916,259-99,011,028)x3 | 4 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自母亲 | 继续妊娠 | |
| 11 | 33岁 | 未见异常 | DS 风险率1︰43;心脏强回声 | [hg19]12q14.1(60,507,735-61,603,306)x1 | 不包含OMIM基因 | 临床意义未明CNV | 1B(-0.6);总分为-0.60分 | 未验证 | 继续妊娠 |
| 序号 | 孕妇年龄 | 胎儿 染色体 核型 | 产前诊断指征 | SNP-array | OMIM基因/个 | 临床 意义 | 证据项 | 综合征 | 父母验证 | 妊娠结局 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 25岁 | 46,XN,der(1)t(1;12)(p36.3;q24.1) | 透明隔腔偏窄、后颅窝池增宽、心包积液 | [hg19]1p36.33p36.32(849,467-2579,267)x1; | 47 | 致病性 CNV | 1A(0)、2H(0.15)、3C(0.9)、4C(0.3)(PMID:25125236,23892090)、5A(0.15);总分为1.50分 | 1p36缺失综合征 | 遗传至母亲 | 终止妊娠 |
| 12q24.13q24.33(114,095,026-133,777,562)x3 | 122 | 致病性CNV | 1A(0)、2H(0)、3C(0.9)、4C(0.3)(patient:402518,296364;PMID:15216553)、5A(0.15);总分为1.35分 | 12号染色体长臂(12q)部分三体综合征 | ||||||
| 2 | 41岁 | 47,XN,+dic(12)(q12)[3]/46,XN[97] | 高龄孕妇;羊水过多;肠道强回声;肾盂扩张 | [hg19]12p13.33q12(173,786-40,380,906)x3-4 | 244 | 致病性CNV | 1A(0)、2H(0)、3C(0.9)、4C(0.9)(patient:282283,284998,339519,266262,389885,350633,270856;PMID:2758689,15633165,2887316)、5A(0.15);总分为1.95分 | PKS | 新发变异 | 终止妊娠 |
| 3 | 29岁 | 47,XN,+i(12)(p10) | 长骨短小;侧脑室增宽;肾盂扩张;NF增厚 | [hg19]12p13.33p11.1(173,786-34,835,641)x4 | 241 | 致病性CNV | 1A(0)、2H(0)、3C(0.9)、4C(0.9)(patient:282283,284998,339519,266262,389885,350633,270856;PMID:2758689,15633165,2887316)、5A(0.15);总分为1.95分 | PKS | 新发变异 | 终止妊娠 |
| 4 | 32岁 | 培养失败 | FGR | [hg19]12p13.31(5,922,932-8,146,162)x3 | 60 | 可能致病性CNV | 1A(0)、2L(0)、3C(0.9)、5C(-0.15);总分为0.75分 | 遗传自母亲 | 终止妊娠 | |
| 15q15.2(43,272,083-43,451,905)x1 | 1 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.15分 | 遗传自父亲 | ||||||
| 5 | 31岁 | 未见异常 | 肠道强回声;心脏强回声 | [hg19]12p13.33(1,953,989-2,773,408)x3 | 2 | 临床意义未明CNV | 1A(0)、3A(0)、5A(0.15);总分为0.15分 | 新发突变 | 继续妊娠 | |
| 6 | 32岁 | 未见异常 | DS风险率1︰164;侵蚀性葡萄胎孕产史 | [hg19]12p13.31(6,027,291-6,685,880)x3 | 17 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.15分 | 遗传自父亲 | 继续妊娠 | |
| 7 | 28岁 | 未见异常 | 既往因胎儿唇裂伴肺静脉异位引流引产;脐血染色体提示12p11.23缺失513.213 kb、16q24.1重复110.97 kb | [hg19]12p11.23(27,283,452-27,796,495)x1 | 3 | 临床意义未明CNV | 1A(0)、3A(0)、4O(-0.3)[gnomad:DEL_12_126655(2/21674)]、5C(-0.15);总分为-0.45分 | 遗传自母亲 | 继续妊娠 | |
| 8 | 33岁 | 未见异常 | 既往18-三体儿引产史 | [hg19]12p13.33(1,889,823-2,539,307)x3 | 5 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自父亲 | 继续妊娠 | |
| 5p15.33(1,014,640-1,277,743)x3 | 5 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自母亲 | ||||||
| 9 | 30岁 | 未见异常 | 既往21-三体儿引产史 | [hg19]12q13.12(50,462,917-50,790,693)x1 | 6 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自母亲 | 继续妊娠 | |
| 10 | 29岁 | 未见异常 | 夫妻双方均为α-地中海贫血基因携带者,胎儿脉络丛囊肿 | [hg19]12q23.1(97,916,259-99,011,028)x3 | 4 | 临床意义未明CNV | 1A(0)、3A(0)、5C(-0.15);总分为-0.45分 | 遗传自母亲 | 继续妊娠 | |
| 11 | 33岁 | 未见异常 | DS 风险率1︰43;心脏强回声 | [hg19]12q14.1(60,507,735-61,603,306)x1 | 不包含OMIM基因 | 临床意义未明CNV | 1B(-0.6);总分为-0.60分 | 未验证 | 继续妊娠 |
| [1] | 王坤, 祝葆华, 刘彦慧. 12p部分三体综合征的临床研究进展[J]. 国际遗传学杂志, 2012, 35(5):300-304. |
| [2] | 王永化, 田琪, 张蕊, 等. 12号染色体三体、嵌合及单亲二体的临床特征及产前诊断[J]. 中国产前诊断杂志(电子版), 2021, 13(1):6-11. |
| [3] |
MOZER JOAQUIM T, PAIVA GRANGEIRO C H, GAONA DE OLIVEIRA GENNARO F, et al. Partial monosomy 4p and trisomy 12q due to a t(4;12)(p16.3;q24.31)familial translocation in two cousins[J]. Mol Syndromol, 2020, 10(5):264-271.
DOI URL |
| [4] |
BOUMAN A, SCHUITEMA A, PFUNDT R, et al. Clinical delineation of a patient with trisomy 12q23q24[J]. Eur J Med Genet, 2013, 56(8):463-469.
DOI PMID |
| [5] |
FETTA A, TONI F, PETTENUZZO I, et al. Structural brain abnormalities in Pallister-Killian syndrome:a neuroimaging study of 31 children[J]. Orphanet J Rare Dis, 2024, 19(1):107.
DOI |
| [6] |
STEPHENS C M, PAVEL A M, MATHIESON S R, et al. Case report:early neonatal EEG in two infants with Pallister Killian syndrome(PKS)[J]. HRB Open Res, 2022, 5:14.
DOI URL |
| [7] | MOORE S. ISCN 2020. An international system for human cytogenomic nomenclature(2020)[J]. J Assoc Genet Technol, 2021, 47(3):133. |
| [8] | 中国预防医学会出生缺陷预防与控制专业委员会产前筛查和诊断学组, 中华医学会医学遗传学分会产前诊断学组. 染色体微阵列分析技术在产前诊断中的应用指南(2023)[J]. 中华妇产科杂志, 2023, 58(8):565-575. |
| [9] |
PASPALIARIS V, VRACHNIS N, ILIODROMITI Z, et al. 7q Deletion/12q duplication is the possible cause of an alobar holoprosencephaly case[J]. Mol Syndromol, 2017, 9(1):52-57.
DOI PMID |
| [10] | PLAZA-BENHUMEA L, MARTIN-DE SARO M D, SANCHEZ-ACOSTA C G, et al. Duplication of 12q24.21q24.33 in a girl with epilepsy,expanding the phenotype[J]. Mol Syndromol, 2022, 13(5):409-418. |
| [11] | OGBUJI C O, ORTEGA L E, WARD H, et al. A rare case of an infant with 1p36 deletion syndrome presenting with systolic heart failure secondary to severe dilated cardiomyopathy[J]. Cureus, 2023, 15(9):e45746. |
| [12] |
ZAVERI H P, BECK T F, HERNÁNDEZ-GARCÍA A, et al. Identification of critical regions and candidate genes for cardiovascular malformations and cardiomyopathy associated with deletions of chromosome 1p36[J]. PLoS One, 2014, 9(1):e85600.
DOI URL |
| [13] |
ZHUANG J, ZHANG N, CHEN Y, et al. Prenatal diagnosis and molecular cytogenetic characterization of fetuses with central nervous system anomalies using chromosomal microarray analysis:a seven-year single-center retrospective study[J]. Sci Rep, 2024, 14(1):2271.
DOI |
| [14] |
JACQUIN C, LANDAIS E, POIRSIER C, et al. 1p36 deletion syndrome:review and mapping with further characterization of the phenotype,a new cohort of 86 patients[J]. Am J Med Genet A, 2023, 191(2):445-458.
DOI URL |
| [15] |
DORAY B, GIRARD-LEMAIRE F, GASSER B, et al. Pallister-Killian syndrome:difficulties of prenatal diagnosis[J]. Prenat Diagn, 2002, 22(6):470-477.
DOI URL |
| [16] |
KAUR M, IZUMI K, WILKENS A B, et al. Genome-wide expression analysis in fibroblast cell lines from probands with Pallister Killian syndrome[J]. PLoS One, 2014, 9(10):e108853.
DOI URL |
| [17] | SKIBBENS R V. Condensins and cohesins-one of these things is not like the other![J]. J Cell Sci, 2019, 132(3):jcs220491. |
| [18] | ZHANG Z, CHU M, BAO Q, et al. Two different copy number variations of the SOX5 and SOX8 genes in yak and their association with growth traits[J]. Animals(Basel), 2022, 12(12):1587. |
| [19] |
ALQAHTANI A S, PUTOUX A, BONNET DUPEYRON M N, et al. Postnatal clinical phenotype of five patients with Pallister-Killian syndrome(tetrasomy 12p):interest of array CGH for diagnosis and review of the literature[J]. Mol Genet Genomic Med, 2019, 7(10):e00939.
DOI URL |
| [20] |
IZUMI K, CULLER D, SOLOMON B, et al. Submicroscopic familial chromosomal translocation between 7q and 12p mimicking an autosomal dominant holoprosencephaly syndrome[J]. Clin Genet, 2010, 78(4):402-404.
DOI PMID |
| [21] | WEISS K, LAZAR H P, KUROLAP A, et al. The CHD4-related syndrome:a comprehensive investigation of the clinical spectrum,genotype-phenotype correlations,and molecular basis[J]. Genet Med, 2020, 22(2):389-397. |
| [22] |
LIU S, WANG Z, JIANG J, et al. Severe forms of Johanson-Blizzard syndrome caused by two novel compound heterozygous variants in UBR1:clinical manifestations,imaging findings and molecular genetics[J]. Pancreatology, 2020, 20(3):562-568.
DOI URL |
| [23] |
COLELLA M, FRÉROT A, NOVAIS A R B, et al. Neonatal and long-term consequences of fetal growth restriction[J]. Curr Pediatr Rev, 2018, 14(4):212-218.
DOI PMID |
| [24] | American College of Obstetricians and Gynecologists' Committee on Practice Bulletins-Obstetrics and the Society for Maternal-Fetal Medicin. ACOG practice bulletin No. 204:fetal growth restriction[J]. Obstet Gynecol, 2019, 133(2):e97-e109. |
| [25] | 中华预防医学会出生缺陷预防与控制专业委员会, 中国优生科学协会基因诊断与精准医学分会, 胡婷, 等. 拷贝数变异检测在产前诊断中的应用指南[J]. 中华医学遗传学杂志, 2020, 37(9):909-917. |
| [26] | 广东省精准医学应用学会遗传病分会, 广东省医学会妇幼保健分会产前诊断学组, 广东省妇幼保健协会产前诊断技术专家委员会, 等. 产前遗传学诊断拷贝数变异和纯合区域的数据分析解读及报告规范化共识[J]. 中华医学遗传学杂志, 2020, 37(7):701-708. |
| [1] | JIN Peiqin, XU Yang, XIONG Yingqiao, PENG Xinxiu. Application of CNV-seq combined with STR typing technology in genetic analysis of early spontaneous abortion products [J]. Laboratory Medicine, 2026, 41(2): 112-117. |
| [2] | GUO Tingting, LOU Huan, HU Hangzhan, YANG Xiaofeng. Analysis of genetic causes and related factors of spontaneous abortion in the first trimester of pregnancy [J]. Laboratory Medicine, 2025, 40(4): 383-387. |
| [3] | ZHANG Xia, YIN Yanjun, FU Zhixuan, KE Jiangwei. Genetic analysis of a child with small supernumerary marker chromosomes by chromosomal microarray analysis [J]. Laboratory Medicine, 2025, 40(2): 131-134. |
| [4] | HUANG Bingyi, ZHAO Qin, YU Donglan, WANG Manyi, ZHU Chunjiang. Genetic analysis of a case of ring chromosome 18 child and literature review [J]. Laboratory Medicine, 2025, 40(2): 135-141. |
| [5] | JIN Chunlei, HU Hui, LIU Jiao, YANG Mufeng, SHAN Qunda, CHEN Penglong. Application role of single nucleotide polymorphism microarray analysis in pregnant women with different prenatal diagnostic indications [J]. Laboratory Medicine, 2024, 39(9): 841-846. |
| [6] | YANG Weiwei, YAO Liying, REN Chenchun, WANG Wenjing, ZHANG Haixia, LI Wen, LI Bo. Prenatal diagnosis result analysis of 884 fetuses with sex chromosomal abnormalities [J]. Laboratory Medicine, 2024, 39(2): 149-154. |
| [7] | FENG Xuan, ZHANG Qinghua, WANG Xing, HE Jing, LIANG Jici, JIA Chunyang, LIN Pengwu, ZHU Shaohua, HAO Shengju. Evaluation of clinical application of expanded non-invasive prenatal testing for chromosome copy number variation [J]. Laboratory Medicine, 2023, 38(8): 730-737. |
| [8] | HAN Xue, WEN Liu, WAN Yang. Analysis of amniotic fluid chromosome karyotype and genome copy number variation in critical or high-risk pregnant women by Down's screening [J]. Laboratory Medicine, 2023, 38(6): 548-552. |
| [9] | ZHANG Chu, WANG Jianhong, LI Rui, XIAO Yanhua, WANG Heng, ZHANG Pinxiao, XU Ningxin, XIA Banban. Results of non-invasive prenatal testing-plus in 5 696 pregnant women [J]. Laboratory Medicine, 2023, 38(6): 553-558. |
| [10] | LUO Yinghua, LIU Bailing, HUANG Jiwei, WANG Yuanliu, ZENG Dingyuan, TANG Ning. Application of CNV-seq in the genetic detection of elevated fetal nuchal translucency [J]. Laboratory Medicine, 2021, 36(9): 951-956. |
| [11] | LI Rui, SHI Panlai, WANG Ailing, WANG Jianhong, XIAO Yanhua, KONG Xiangdong. Application of single nucleotide polymorphism array for fetuses with thickened nuchal translucency [J]. Laboratory Medicine, 2020, 35(2): 142-147. |
| [12] | HU Wenjing, CHEN Qinfang, WU Yi, HAN Xu, GUO Xiaokui, TAO Jiong. Application of a modified copy number variation detection technique in spontaneous miscarriage heredity [J]. Laboratory Medicine, 2019, 34(7): 637-642. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||